Europe Organ Preservation Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

The Europe organ preservation market encompasses products and technologies designed to maintain organ viability during transport from donor to recipient, including static cold storage solutions, hypothermic machine perfusion devices, and normothermic perfusion systems. Valued at approximately $75 million in 2025, the market is experiencing steady expansion as European healthcare systems grapple with growing organ failure rates and transplant demand. Static cold storage remains the dominant preservation technique, though machine perfusion technologies are gaining clinical acceptance.

• •Market valued at approximately $75 million in 2025 with projected 6.11% annual growth
• •Primary preservation methods include static cold storage, hypothermic machine perfusion, and normothermic machine perfusion
• •Key applications span kidney, liver, heart, lung, and pancreas transplants

Rising prevalence of end-stage renal disease, liver cirrhosis, and cardiovascular conditions across Europe is increasing demand for organ transplants and, consequently, preservation technologies. Advancements in machine perfusion have significantly extended organ viability windows, reducing discard rates and expanding the donor pool. Additionally, favorable regulatory frameworks supporting organ donation initiatives and growing healthcare expenditure in Western Europe are accelerating market expansion.

• •Increasing organ failure incidence and transplant waiting lists across European nations
• •Technological improvements in machine perfusion reducing organ ischemic injury
• •Supportive government policies and funding for organ donation infrastructure

The market is segmented by product type into preservation solutions and preservation devices, with solutions accounting for the largest share through traditional cold storage applications. By preservation technique, static cold storage leads the market, though machine perfusion segments are growing rapidly. Geographically, Western Europe dominates the market, followed by Northern Europe, with Eastern Europe representing an emerging opportunity due to developing transplant infrastructure.

• •Western Europe leads regionally due to advanced transplant infrastructure in Germany, France, and the United Kingdom
• •Kidney and liver preservation represent the largest application segments
• •Eastern European markets show accelerating growth as transplant programs expand

What are the recent trends and outlook?

The market is witnessing a clear shift from static cold storage toward machine perfusion technologies, with normothermic machine perfusion emerging as a transformative approach that maintains organs at body temperature. Portable and compact perfusion devices are gaining favor for their ability to extend preservation time and improve organ quality assessment. Over the forecast period, integration of artificial intelligence for organ viability assessment and continued regulatory approvals for new preservation technologies are expected to drive further market evolution.

• •Normothermic machine perfusion adoption increasing for liver, lung, and heart transplants
• •Portable perfusion devices enabling longer transport distances between donor and recipient
• •AI-assisted organ assessment tools being developed to optimize allocation decisions